383 related articles for article (PubMed ID: 18057241)
21. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.
Miller WE; Mosialos G; Kieff E; Raab-Traub N
J Virol; 1997 Jan; 71(1):586-94. PubMed ID: 8985387
[TBL] [Abstract][Full Text] [Related]
22. Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathway.
Dudziak D; Kieser A; Dirmeier U; Nimmerjahn F; Berchtold S; Steinkasserer A; Marschall G; Hammerschmidt W; Laux G; Bornkamm GW
J Virol; 2003 Aug; 77(15):8290-8. PubMed ID: 12857898
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways.
Zhang J; Jia L; Lin W; Yip YL; Lo KW; Lau VMY; Zhu D; Tsang CM; Zhou Y; Deng W; Lung HL; Lung ML; Cheung LM; Tsao SW
J Virol; 2017 Mar; 91(6):. PubMed ID: 28053105
[TBL] [Abstract][Full Text] [Related]
24. Modulation of MicroRNA Cluster miR-183-96-182 Expression by Epstein-Barr Virus Latent Membrane Protein 1.
Oussaief L; Fendri A; Chane-Woon-Ming B; Poirey R; Delecluse HJ; Joab I; Pfeffer S
J Virol; 2015 Dec; 89(23):12178-88. PubMed ID: 26401047
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1.
Franken M; Devergne O; Rosenzweig M; Annis B; Kieff E; Wang F
J Virol; 1996 Nov; 70(11):7819-26. PubMed ID: 8892903
[TBL] [Abstract][Full Text] [Related]
26. The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB.
Zuo L; Yu H; Liu L; Tang Y; Wu H; Yang J; Zhu M; Du S; Zhao L; Cao L; Li G; Lu J
Oncotarget; 2015 Dec; 6(38):41033-44. PubMed ID: 26517512
[TBL] [Abstract][Full Text] [Related]
27. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit.
Ning S; Hahn AM; Huye LE; Pagano JS
J Virol; 2003 Sep; 77(17):9359-68. PubMed ID: 12915551
[TBL] [Abstract][Full Text] [Related]
28. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha.
Wakisaka N; Kondo S; Yoshizaki T; Murono S; Furukawa M; Pagano JS
Mol Cell Biol; 2004 Jun; 24(12):5223-34. PubMed ID: 15169887
[TBL] [Abstract][Full Text] [Related]
30. Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival.
Lin KM; Lin SJ; Lin JH; Lin PY; Teng PL; Wu HE; Yeh TH; Wang YP; Chen MR; Tsai CH
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776277
[TBL] [Abstract][Full Text] [Related]
31. Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expression.
Johansson P; Jansson A; Rüetschi U; Rymo L
J Virol; 2009 Feb; 83(3):1393-401. PubMed ID: 19019967
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus microRNAs regulate B cell receptor signal transduction and lytic reactivation.
Chen Y; Fachko D; Ivanov NS; Skinner CM; Skalsky RL
PLoS Pathog; 2019 Jan; 15(1):e1007535. PubMed ID: 30615681
[TBL] [Abstract][Full Text] [Related]
33. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
Thornburg NJ; Raab-Traub N
J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways.
Yin Q; McBride J; Fewell C; Lacey M; Wang X; Lin Z; Cameron J; Flemington EK
J Virol; 2008 Jun; 82(11):5295-306. PubMed ID: 18367535
[TBL] [Abstract][Full Text] [Related]
35. Modulation of LMP1 protein expression by EBV-encoded microRNAs.
Lo AK; To KF; Lo KW; Lung RW; Hui JW; Liao G; Hayward SD
Proc Natl Acad Sci U S A; 2007 Oct; 104(41):16164-9. PubMed ID: 17911266
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of latent membrane protein 1 impairs the growth and tumorigenesis of latency II Epstein-Barr virus-transformed T cells.
Ndour PA; Brocqueville G; Ouk TS; Goormachtigh G; Morales O; Mougel A; Bertout J; Melnyk O; Fafeur V; Feuillard J; Coll J; Adriaenssens E
J Virol; 2012 Apr; 86(7):3934-43. PubMed ID: 22258264
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence.
Lu F; Weidmer A; Liu CG; Volinia S; Croce CM; Lieberman PM
J Virol; 2008 Nov; 82(21):10436-43. PubMed ID: 18753206
[TBL] [Abstract][Full Text] [Related]
38. The LMP1 promoter can be transactivated directly by NF-kappaB.
Demetriades C; Mosialos G
J Virol; 2009 May; 83(10):5269-77. PubMed ID: 19279104
[TBL] [Abstract][Full Text] [Related]
39. Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.
D'Souza BN; Edelstein LC; Pegman PM; Smith SM; Loughran ST; Clarke A; Mehl A; Rowe M; Gélinas C; Walls D
J Virol; 2004 Feb; 78(4):1800-16. PubMed ID: 14747545
[TBL] [Abstract][Full Text] [Related]
40. Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation.
Gewurz BE; Mar JC; Padi M; Zhao B; Shinners NP; Takasaki K; Bedoya E; Zou JY; Cahir-McFarland E; Quackenbush J; Kieff E
J Virol; 2011 Jul; 85(13):6764-73. PubMed ID: 21543491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
